about
sameAs
Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer.Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapyNomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer.Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements.Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph nodeA prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer.The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registrationRadiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parametersPreoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer.Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report.High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma.Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy.Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion.Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin.A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer.Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma.Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.Four-dimensional dose evaluation using deformable image registration in radiotherapy for liver cancer.Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors.Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.Stereotactic body radiation therapy for locally advanced pancreatic cancerDiagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glandsRadiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomesFailure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer
P50
Q33389467-68D1AD74-2F02-4865-A961-CCE0A464B16CQ33417569-FFFF5946-F645-4D26-9610-052D82F617DEQ33821843-485387A3-12A8-48F5-868C-738A7AEB8098Q33918074-58232CCC-5964-4285-83A1-6802741ECAE8Q35047457-B709D54B-032A-4A7A-ABAC-405AE5A215C5Q35739788-0DC20CEE-BD84-410A-914B-22A52A22AE2AQ35872656-5224D59E-E97A-4D49-8FC8-E92B7D93D956Q36201159-C9F44307-B87A-4875-87CA-A8E052FAEF3EQ36537056-BF136C18-29D1-42B0-91E9-B42F1E6400D6Q36684017-8775060D-C2A6-4B8E-97D0-33086DC948F3Q36972681-83F52F7A-A3EB-475E-AB9F-444AFAD98794Q37277060-BEFEE2E7-D645-4DDE-AED5-4B05A7AAE842Q37343477-414F4461-0497-420F-A40B-44AABDBEA3D0Q37549491-D42416E2-F960-4DBF-BB0A-C089CC1638CCQ37716519-44BAE297-82E7-40A2-BC3E-A24AADE08610Q37845206-EA1B8A18-5F31-4085-A600-22B86546D429Q38409436-4DA9500E-FCED-46D8-97BB-44064D314A2AQ38971258-3319A504-C99F-4482-A7C4-FF5CF1D34E5EQ41858392-CF467A7F-C7C5-4E91-9500-CF056A865A6EQ43988301-EF264638-6D9D-48F1-910B-461A3858EC6FQ46480921-5E14F152-0705-4B44-AA33-0BB66048CB96Q50074841-9662EFF8-FDE4-4ECC-B343-F831E231AB8AQ53187661-4EC50DFC-95E9-48A6-B6B2-27570DE22DCDQ53346448-416B5F49-7AB1-4080-9C88-9083622D62AFQ53389116-F879553E-34B1-4DAC-B1F5-C0D03B9C053AQ53511344-2181469C-604C-4EAF-BFA6-F69498700149Q53604043-132413CC-C801-49F9-9661-262CB5ACC14CQ64052570-630565EE-6937-47BD-A2D1-3994F3FB60DDQ84100452-EEBC6ED5-52E6-4F0E-87F9-A7012E9696E8Q84214482-C99B78DE-6546-412D-9A6F-66DB86027A09Q84356913-9E4A7AFC-3E92-4483-812D-77CC7B698433
P50
description
researcher ORCID ID = 0000-0002-1088-0174
@en
wetenschapper
@nl
name
Jin-hong Park
@ast
Jin-hong Park
@en
Jin-hong Park
@es
Jin-hong Park
@nl
type
label
Jin-hong Park
@ast
Jin-hong Park
@en
Jin-hong Park
@es
Jin-hong Park
@nl
altLabel
Jin-Hong Park
@en
prefLabel
Jin-hong Park
@ast
Jin-hong Park
@en
Jin-hong Park
@es
Jin-hong Park
@nl
P106
P1153
22635319800
P31
P496
0000-0002-1088-0174